Covaxin overall 77.8% effective, claims Bharat Biotech in final Phase 3 data, yet to be peer-reviewed

Bharat Biotech’s Covaxin is overall 77.8 per cent effective “against symptomatic COVID-19”, the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The…

Similar Articles


Most Popular


You cannot copy content of this page

In Order to Strengthen Democracy, Citizens Should Bear the Cost of Impartial Journalism. Join 1-Rupee Campaign